Search hospitals
>
California
>
Palo Alto
Lucile Packard Children's Hospital Stanford University
Claim this profile
Palo Alto, California 94304
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Neuroblastoma
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Solid Tumors
418 reported clinical trials
44 medical researchers
Summary
Lucile Packard Children's Hospital Stanford University is a medical facility located in Palo Alto, California. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Lucile Packard Children's Hospital Stanford University is involved with conducting 418 clinical trials across 851 conditions. There are 44 research doctors associated with this hospital, such as Jay Michael S. Balagtas, Robert Lowsky, MD, Gail L Wright, MD, and Sonia Partap, MD.
Area of expertise
Cancer
Lucile Packard Children's Hospital Stanford University has run 63 trials for Cancer. Some of their research focus areas include:
Brain Tumor
Lucile Packard Children's Hospital Stanford University has run 53 trials for Brain Tumor. Some of their research focus areas include:
Top PIs
Jay Michael S. Balagtas
Lucile Packard Children's Hospital Stanford University
8 years of reported clinical research
Robert Lowsky, MD
Stanford University
2 years of reported clinical research
Gail L Wright, MD
Florida Cancer Specialists - North Region
6 years of reported clinical research
Sonia Partap, MD
Lucille Packard Children's Hospital at Stanford University Medical Center
5 years of reported clinical research
Clinical Trials running at Lucile Packard Children's Hospital Stanford University
Acute Lymphoblastic Leukemia
Testicular cancer
Crohn's Disease
Brain Cancer
Brain Tumor
Neuroblastoma
Adrenoleukodystrophy
Pneumonia
Wilms Tumor
Ovarian Carcinoma
Palbociclib + Chemotherapy
for Acute Lymphoblastic Leukemia
With this research study has following goals * To confirm the highest tolerable dose of palbociclib in combination with chemotherapy is safe and well-tolerated. * To learn more about side effects of palbociclib in combination with chemotherapy; * To learn more about the biological effects of palbociclib on the cells in your body
Recruiting
3 awards
Phase 1
21 criteria
Levocarnitine
for Chemotherapy-Related Liver Protection in Leukemia and Lymphoma
This phase III trial compares the effect of adding levocarnitine to standard chemotherapy versus (vs.) standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for the treatment of acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), and mixed phenotype acute leukemia (MPAL). However, in adolescent and young adults (AYA) ages 15-39 years, liver toxicity from asparaginase is common and often prevents delivery of planned chemotherapy, thereby potentially compromising outcomes. Some groups of people may also be at higher risk for liver damage due to the presence of fat in the liver even before starting chemotherapy. Patients who are of Japanese descent, Native Hawaiian, Hispanic or Latinx may be at greater risk for liver damage from chemotherapy for this reason. Carnitine is a naturally occurring nutrient that is part of a typical diet and is also made by the body. Carnitine is necessary for metabolism and its deficiency or absence is associated with liver and other organ damage. Levocarnitine is a drug used to provide extra carnitine. Laboratory and real-world usage of the dietary supplement levocarnitine suggests its potential to prevent or reduce liver toxicity from asparaginase. The overall goal of this study is to determine whether adding levocarnitine to standard of care chemotherapy will reduce the chance of developing severe liver damage from asparaginase chemotherapy in ALL, LL and/or MPAL patients.
Recruiting
2 awards
Phase 3
ECG-Guided Umbilical Vessel Catheterization
for Acute Lymphoblastic Leukemia
Umbilical venous catheters (UVC) are typically places with poor guidance and some radiological confirmation. Misplacement of the catheter could lead to its placement in other unintended anatomical areas such as the liver or the spleen, which could be detrimental in critically-ill infants. Our study aims at using a more non-invasive means of placing and continuously monitoring catheter placement using superficial electrocardiogram (ECG) tracings.
Recruiting
1 award
N/A
3 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Lucile Packard Children's Hospital Stanford University?
Lucile Packard Children's Hospital Stanford University is a medical facility located in Palo Alto, California. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Lucile Packard Children's Hospital Stanford University is involved with conducting 418 clinical trials across 851 conditions. There are 44 research doctors associated with this hospital, such as Jay Michael S. Balagtas, Robert Lowsky, MD, Gail L Wright, MD, and Sonia Partap, MD.
Where is Lucile Packard Children's Hospital Stanford University located?
Lucile Packard Children's Hospital Stanford is located at 725 Welch Road, Palo Alto, CA 94304. It is part of the Stanford University Medical Center. The main entrance is accessible from Welch Road.
Who should I call to ask about financial aid or insurance network?
**Lucile Packard Children's Hospital Stanford University - Financial Assistance and Insurance Inquiries** **Financial Assistance:** - **Phone:** 844-498-2900 (Monday – Friday, 8:00 a.m. – 5:00 p.m.) - **Mail:** SHC Patient Financial Assistance, Patient Financial Services, P.O. BOX 740715, Los Angeles, CA 90074-0715 **Financial Counseling:** - **Phone:** 650-736-2273 - **Details:** Contact the Financial Counseling Team to discuss financial assistance applications. For additional support, visit the Stanford Medicine Children's Health Financial Assistance Application page.
What insurance does Lucile Packard Children's Hospital Stanford University accept?
Lucile Packard Children's Hospital Stanford University accepts a range of insurance plans, such as Anthem Blue Cross, Medi-Cal Fee For Service, and Blue Shield of California. As part of the Stanford Health Care network, it has agreements with numerous health plans and medical groups. For the most accurate and current information on accepted insurance plans, contact the hospital directly.
What awards or recognition has Lucile Packard Children's Hospital Stanford University received?
Lucile Packard Children's Hospital Stanford is celebrated as one of the 100 great hospitals in the nation by Becker's Hospital Review and has earned Magnet® Recognition for outstanding nursing practice, teamwork, and patient care. It consistently ranks in the top 20 of all children's hospitals by U.S. News & World Report. The hospital is renowned for its excellence in neonatology, nephrology, pulmonology, and endocrinology.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.